Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 粉剂(内部使用的)

Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 颗粒剂(内部使用的)

Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 粉剂(内部使用的)

Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 粉剂(内部使用的)

Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 片

Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 粉剂(内部使用的)

Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 片

Singapur - kineski - HSA (Health Sciences Authority)

kaiser pharmaceutical (singapore) private limited - 粉剂(内部使用的)

Tajvan - kineski - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

永勝藥品工業股份有限公司 嘉義縣民雄鄉興南村頭橋工業區工業三路6之3號 (30853589) - thiamine hydrochloride;;riboflavin (vit b2);;pyridoxine hcl;;cyanocobalamin (vit b12);;nicotinamide (hcl);;pantothenate calcium;;silymarin (exsiccated fructus cardui marianus extract) - 膠囊劑 - silymarin (exsiccated fructus cardui marianus extract) (5656991100) mg; nicotinamide (hcl) (8810009310) mg; thiamine hydrochloride (8810100900) mg; riboflavin (vit b2) (8810200400) mg; pyridoxine hcl (8810600300) mg; cyanocobalamin (vit b12) (8811200300) ug; pantothenate calcium (8812300200) mg - liver therapy - 慢性肝病的營養補給。

Tajvan - kineski - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - plerixafor - 注射劑 - 主成分 () ; plerixafor (9200092800) mg - plerixafor - 成人與顆粒球群落形成刺激因子(g-csf)併用，驅動造血幹細胞至周邊血液供收集以施行自體移植；適用於須施行自體移植之非何杰金氏淋巴瘤或多發性骨髓瘤的成人病人，但驅動不佳者。兒童 (1歲至小於18歲)與顆粒球群落形成刺激因子(g-csf)併用，驅動造血幹細胞至周邊血液供收集以施行自體移植；適用於患有淋巴瘤或實體惡性腫瘤及有以下任一情況的兒童：-使用g-csf驅動後，循環中的造血幹細胞在預期收集當天所能收集到的細胞數太少(不論是否併用化療)，或-先前曾無法收集到足量的造血幹細胞。